Assembly Biosciences (ASMB): Price-to-Projected Revenue Ratio

Assembly Biosciences (ASMB) - corporate logo

Geopolitical tensions and sanctions are hindering global hepatitis research, a trend reflected in the indicator's price action on the GURU.Markets chart; meanwhile, the value of 5.40 corresponds to the current forward P/S metric of the business. Assembly Biosciences (ASMB) is scaling its virology portfolio through external partner capital, leveraging a deep scientific foundation and the development of core protein inhibitors to combat liver diseases.

ASMB assemblybio.com: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Assembly Corp (ASMB)

- current price and projected stock value:
Stock Price Assembly Biosciences, Inc.|ASMB - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value Assembly Corp|ASMB - Company Buyout Price
- book value of equity indicators:
Net Assets per Single Share Assembly Biosciences|ASMB - Book Valuation of Business|Market Capitalization to Book Value Ratio assemblybio.com|ASMB - Company Assets
- company liabilities and liquidity data:
Debt to Equity Assembly Biosciences|ASMB - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Assembly Biosciences|ASMB - Company Debts|Debt to Book Capitalization Ratio Assembly Corp|ASMB - Company Long-Term Debt|Company Current Liabilities Assembly Biosciences|Quick Liquidity Indicator assemblybio.com
- business earnings and investment ratios data:
ASMB - Final Profit|Projected Future Earnings Assembly Biosciences|ASMB - Price to Earnings Ratio|Forward P/E Multiple Assembly Biosciences Inc|ASMB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Assembly Corp|ASMB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Assembly Biosciences|ASMB - Net earnings per share for the last four quarters|Quarterly EPS earnings growth assemblybio.com|ASMB - Net earnings per share growth this year|Earnings growth forecast for next year Assembly Biosciences
- sales volume and revenue indicators:
ASMB - Company Gross Revenue|Projected Sales Volume Assembly Biosciences, Inc.|ASMB - Price to Sales|Price-to-Projected Revenue Ratio Assembly Corp
Summary company analytics:ASMB (Assembly Biosciences, Inc.)
Original product of Assembly Corp

For the biotechnological profile of Assembly Biosciences (ASMB), the forward P/S trend serves as an indicator of market expectations regarding future cash flows. This metric compares current market capitalization with projected revenue, demonstrating a risk premium given the business's dependence on US and EU regulatory verdicts, where the absence of a commercial market leaves the valuation hostage to clinical trial results.

Who Assembly Biosciences competes with

Forward P/S Multiple ARWR (Arrowhead Pharmaceuticals, Inc.)|Forward P/S Multiple Mirum Pharmaceuticals, Inc. MIRM|DVAX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Tekmira Pharmaceuticals ABUS|Inventiva S.A. (IVA) - Price-to-Projected Revenue Ratio|GYRE - Market Cap to Expected Sales Ratio|GALT (Galectin Therapeutics, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Genfit Corp GNFT|Price-to-Projected Revenue Ratio DURECT Corporation (DRRX)|Forward Price-to-Revenue Multiple aligos.com ALGS|Forward P/S Multiple BIVI (BioVie)|Galmed Pharmaceuticals Ltd - Price-to-Projected Revenue Ratio|NDRA - Price-to-Projected Revenue Ratio|HEPA: Price-to-Projected Revenue Ratio